QSC ships research-grade eloralintide (MEDI0382/cotadutide) to NSW, Australia via International. As one of the first suppliers globally to stock eloralintide, QSC gives researchers in New South Wales early access to this dual GLP-1R/GCGR agonist — positioning your lab ahead of the research wave before broader supply becomes available.
Eloralintide’s GCGR component drives direct hepatic CPT1A-mediated fat oxidation — producing ~40–50% liver fat reduction in Phase 2 NASH trials with only ~10–11% weight loss. This is the mechanism absent from semaglutide and tirzepatide that makes eloralintide the dedicated tool for NASH/MAFLD and hepatic lipid biology research.
Shipping to New South Wales: International · 7–14 business days · Tracked · Discreet packaging · Janoshik COA code with every order.
Can I buy eloralintide in New South Wales?
Yes — QSC ships research-grade eloralintide (MEDI0382/cotadutide) to NSW, Australia via International. Estimated delivery: 7–14 business days. ≥99% HPLC purity, Janoshik independent COA. For in vitro laboratory research only.
What is eloralintide (MEDI0382)?
Eloralintide (MEDI0382/cotadutide) is a 31-amino acid dual GLP-1R/GCGR co-agonist developed by AstraZeneca/MedImmune. Phase 2 data: ~10–11% weight loss, ~40–50% liver fat reduction (MRI-PDFF) in NASH trials. The GCGR component drives direct hepatic fat oxidation via CPT1A — distinct from GLP-1R-only compounds like semaglutide. QSC is among the first suppliers to stock it.
How long does eloralintide shipping take to New South Wales?
QSC ships eloralintide to New South Wales via International. Estimated delivery: 7–14 business days. All orders include tracking and Janoshik COA verification code.
Why choose QSC for eloralintide research?
QSC provides first-mover access to eloralintide before most suppliers stock it — giving researchers in New South Wales a competitive advantage. Every batch: ≥99% HPLC, MS confirmed, Janoshik independent COA (verify at verify.janoshik.com). US Domestic Warehouse for US orders.
Buy Eloralintide in New South Wales — QSC First Mover
≥99% HPLC · Janoshik COA · Research-grade · 7–14 business days to New South Wales
Research Use Only: Eloralintide is sold by QSC strictly for in vitro laboratory research purposes only. Not for human or veterinary use. Not FDA approved for clinical use.
